InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,626.02
(
0.54%
)
US TECH 100
18,986.40
(
0.30%
)
Dow Jones
41,393.78
(
0.72%
)
Brent Oil
71.83
(
0.00%
)
Bitcoin
59,949.41
(
-1.04%
)
Post# of 6451
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

randychub

Send PM Follow Ignore
Followers 26
Posts 2629
Boards Moderated 0
Alias Born 10/23/2003

randychub

Re: None

Thursday, 10/05/2006 8:11:52 AM

Thursday, October 05, 2006 8:11:52 AM

Post# of 6451
Dvax was on CNBC this morning - Up over $2 a share a share on 14 patient data for allergies. They did interview one of the patients in the study. His symptoms where better but he continued to take other medicine, just not as often.

Compare this to Cobalis with 1 completed phase 3 trial, 715 patients and two more trials to be completed in Nov. .95 cents a share.

Randy
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up